Core Viewpoint - The brain-computer interface concept has seen significant market activity, with notable stock price increases among related companies on December 5th [1][2] Group 1: Stock Performance - Nanjing Panda reached its daily limit up, indicating strong investor interest [1][2] - Dineike experienced a nearly 10% increase in stock price, reflecting positive market sentiment [1][2] - Other companies in the sector, including Beiyikang, Innovation Medical, Chengyitong, and Aipeng Medical, also saw their stock prices rise [1][2]

Core Viewpoint - Nanjing Panda Electronics Co., Ltd. (00553) experienced a nearly 7% increase in stock price, reaching 4.86 HKD with a trading volume of 71.7075 million HKD, following news related to the upcoming 2025 Brain-Computer Interface Conference in Shanghai [1]. Group 1: Event Overview - The Shanghai Municipal Science and Technology Commission held a press conference on December 1 for the 2025 Brain-Computer Interface Conference, scheduled for December 4-5, themed "Brain Link World · Intelligent Shanghai" [1]. - The conference will feature one main forum, eight sub-forums, one product launch, one developer forum, and four competitions, showcasing the latest advancements and application prospects in brain-computer interface technology [1]. Group 2: Industry Development - The conference will take place in the "Brain Intelligence World" future industry cluster area located in the Minhang District, near Fudan University Huashan Hospital [1]. - The local government and the Shanghai Municipal Science and Technology Commission are establishing platforms for concept validation, testing certification, and pilot processing to attract outstanding domestic and international teams and companies, aiming to make Shanghai a global hub for brain-computer interface innovation [1]. Group 3: Clinical Trials and Research - The first domestic implantable brain-computer interface GCP clinical trial, the world's first real-time Chinese language decoding IIT trial, the first domestic cerebrospinal interface IIT trial, and the first domestic invasive brain-computer interface system prospective clinical trial have been initiated, receiving significant attention from international journals such as Nature and MIT Technology Review [1].

Core Viewpoint - The A-share market has seen a strong performance in the telecommunications equipment sector, with several stocks experiencing significant gains [1] Group 1: Stock Performance - Zhongfutong has risen over 11% [1] - Yongding Co., TeFa Information, and Guomai Technology have reached the 10% limit up [1] - Taicheng Light has increased by over 9% [1] - Nanjing Panda has gained over 7% [1] - Guangku Technology has risen by over 6% [1] - Wuhan Fangu has increased by over 5% [1] - Yinghua Electronics has also seen an increase of over 5% [1] - Other companies like Aled, Canqin Technology, Guodun Quantum, and Wanma Technology have risen by over 4% [1]

Group 1: Industrial Mother Machine Sector - The industrial mother machine sector shows a positive trend with a total index increase of 1.29% to 1754.21 [2] - Key stocks in this sector include: - GuoJi Heavy Industry (601399) with a price of 4.63, up by 9.98% and 42.46% over the past five days [2] - China First Heavy Industries (601106) at 3.42, also up by 9.97% and 13.62% over the last five days [2] - Weihong Co., Ltd. (300508) at 38.12, increasing by 9.29% and 10.05% in five days [2] - Other notable performers include: - Yuhuan CNC (002903) at 24.54, up by 6.70% [2] - Ruineng Technology (603933) at 30.40, with a 5.89% increase [2] Group 2: Brain-Computer Interface Sector - The brain-computer interface sector experienced significant activity, highlighted by the upcoming "Brain Link World, Intelligence Gathering in Shanghai" conference scheduled for December 4-5, 2025 [3] - Key stocks in this sector include: - Dineike (300884) with a price of 16.82, up by 14.34% and 18.09% over the past five days [3] - Nanjing Panda (600775) at 12.55, increasing by 9.99% and 13.78% [3] - Chengyitong (300430) at 18.99, up by 3.94% [3] - Other stocks showing positive movement include: - Beiyikang (920199) at 34.70, up by 3.89% [3] - Innovation Medical (002173) at 22.29, with a 3.05% increase [3]

Core Viewpoint - The A-share market is experiencing a surge in the brain-computer interface (BCI) concept, with notable stock increases among several companies following the 2025 Brain-Computer Interface Conference held in Shanghai from December 4 to 5 [1] Company Performance - Dineike (狄耐克) saw its stock price increase by over 14% [1] - Nanjing Panda (南京熊猫) reached the daily limit with a 10% increase [1] - Other companies such as Chengyitong (诚益通), Innovation Medical (创新医疗), Sanbo Brain Science (三博脑科), and Aipeng Medical (爱朋医疗) also experienced stock price increases [1]

Core Viewpoint - Nanjing Panda Electronics Co., Ltd. (00553) saw a nearly 7% increase in stock price, reaching HKD 4.86 with a trading volume of HKD 71.7075 million, following news about the upcoming 2025 Brain-Computer Interface Conference in Shanghai [1] Group 1: Event Overview - The Shanghai Municipal Science and Technology Commission held a press conference for the 2025 Brain-Computer Interface Conference, scheduled for December 4-5, themed "Brain Link World · Intelligence Gathering in Shanghai" [1] - The conference will feature one main forum, eight sub-forums, one product launch, one developer forum, and four competitive events, showcasing the latest advancements and application prospects in brain-computer interface technology [1] Group 2: Industry Development - The conference will take place in the "Brain Intelligence World" future industry cluster area located in the Minhang District, near Fudan University Huashan Hospital [1] - The local government and the Science and Technology Commission are establishing platforms for concept validation, testing certification, and pilot processing to attract outstanding domestic and international teams and companies, aiming to make Shanghai a globally influential innovation source and industrial hub for brain-computer interfaces [1] Group 3: Clinical Trials and Research - The first domestic implantable brain-computer interface GCP clinical trial, the world's first real-time Chinese language decoding IIT trial, the first domestic cerebrospinal interface IIT trial, and the first domestic invasive brain-computer interface system prospective clinical trial have been launched, receiving significant attention from international journals such as "Nature" and "MIT Technology Review" [1]

南京熊猫电子股份有限公司股东会议事规则 南京熊猫电子股份有限公司 股东会议事规则 （2025 年 12 月修订） 第一章 总则 （二）审议批准董事会的报告； 1 第一条 为了规范南京熊猫电子股份有限公司（以下简称"公司"）股东会的 议事方法和程序，保证公司股东会依法行使职权，及决策的科学性和正确性，切实 保障股东依法正确行使股东权利，履行股东义务。根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《南 京熊猫电子股份有限公司章程》（以下简称"公司章程"）及其他有关规定，制定本 规则。 第二条 本规则对公司全体股东、董事、董事会秘书及其他有关人员具有约束 力。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当勤 勉尽责，确保股东会正常召开和依法行使职权。 第二章 股东会的职权及召集 第三条 股东会是公司的权力机构，在《公司法》和公司章程规定的范围内依 法行使职权。 股东会行使下列职权： （一）选举和更换董事，决定有关董事的报酬事项； 南京熊猫电子股份有限公司股东会议事规则 （三）审议批准公司年度财务预算方案、决算方案； （四）审议批准 ...

南京熊猫电子股份有限公司董事会议事规则 南京熊猫电子股份有限公司 董事会议事规则 （2025 年 12 月修订） 第一章 总则 第一条 为了规范南京熊猫电子股份有限公司（以下简称"公司"）董事会 的议事方法和程序，保证公司董事会决策的科学性和正确性，充分发挥董事会的 作用，根据《中华人民共和国公司法》《上海证券交易所股票上市规则》、本公司 章程及其他有关规定，制定本规则。 第二条 本规则对公司全体董事、总经理、副总经理、总会计师、董事会秘 书及其他高级管理人员具有约束力。 第二章 董事会组成 第三条 公司董事会由九名董事组成，董事会设董事长一人、可以设副董事 长一至二人。 董事会成员中，至少应有三名独立董事，独立董事由独立人士担任。 董事会成员中应当有1名公司职工代表董事。职工代表董事由公司职工通过 职工代表大会、职工大会或者其他形式民主选举产生，无需提交股东会审议。 董事会指定一至数名董事担任执行董事，执行董事处理董事会授权的事宜。 第四条 董事由股东会选举产生或者更换，并可在任期届满前由股东会解 除其职务。董事任期三年，董事任期届满，可以连选连任。 董事任期从就任之日起计算，至本届董事会任期届满时为止。董 ...

南京熊猫电子股份有限公司章程 南京熊猫电子股份有限公司 （2025年12月修订） 章 程 - 1 - | 第一章 | 总则 | | 3 | | --- | --- | --- | --- | | 第二章 | 经营宗旨和范围 | | 5 | | 第三章 | 股份和注册资本 | | 6 | | 第四章 | 股份增减和回购 | | 9 | | 第五章 | 股票和股东名册 | | 11 | | 第六章 | 股东的权利和义务 | | 12 | | 第七章 | 股东会 | | 18 | | 第八章 | 董事和董事会 | | 31 | | 第九章 | 高级管理人员 | | 44 | | 第十章 | 党委 | | 46 | | 第十一章 | 财务会计制度、利润分配和审计 | | 47 | | 第十二章 | 会计事务所的聘任 | | 52 | | 第十三章 | 保险 | | 53 | | 第十四章 | 劳动管理 | | 53 | | 第十五章 | 工会组织 | | 54 | | 第十六章 | 合并、分立、增资、减资 | | 54 | | 第十七章 | 公司解散和清算 | | 56 | | 第十八章 | 公司章程的修订 | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 夏德傳 本 公 告 乃 根 據 香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）證 券 上 市 規 則 第 13.10B條 規 定 而 作 出。 茲 載 列 南 京 熊 猫 電 子 股 份 有 限 公 司（「本公司」）在 中 華 人 民 共 和 國 上 海 證 券 交 易 所 網 站 刊 登 的《南 京 熊 猫 電 子 股 份 有 限 公 司2025年第二次臨時 股 東 大 會、2025年第一次A股類別股東會及2025年第一次H股類別股東 會 決 議 公 告》，僅 供 參 閱。 承董事會命 海外監管公告 南京熊猫電子股份有限公司 董事長 中華人民共和國‧南京 二零二五年十二月四日 於 本 公 告 日 期，董 事 會 包 括 執 行 董 事：夏 德 傳 先 生、胡 回 春 先 生；非 執 行 董 事：劉 劍 鋒 先 生、胡 進 先 ...